Elementis plc (ELMTY)
| Market Cap | 1.21B -0.6% |
| Revenue (ttm) | 624.90M +7.6% |
| Net Income | 74.10M |
| EPS | 0.51 |
| Shares Out | n/a |
| PE Ratio | 18.28 |
| Forward PE | 16.18 |
| Dividend | 0.18 (1.89%) |
| Ex-Dividend Date | Aug 14, 2026 |
| Volume | 100 |
| Open | 11.40 |
| Previous Close | 9.39 |
| Day's Range | 9.39 - 11.40 |
| 52-Week Range | 7.31 - 11.40 |
| Beta | 0.92 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 5, 2027 |
About Elementis
Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Coatings and Personal Care. The Coatings segment offers production of rheological modifiers and additives for decorative and industrial coatings; and performance chemicals for the energy sector. This segment provides products for applications in architectural and industrial coatings, adhesives, and sealants and construction additives. The Personal Care segment offers rheological modifiers... [Read more]
Financial Performance
In 2025, Elementis's revenue was $597.50 million, a decrease of -1.04% compared to the previous year's $603.80 million. Losses were -$45.50 million, -4.81% less than in 2024.
Financial StatementsNews
Elementis Slides: Status update
Elementis has posted slides in relation to its latest quarterly earnings report, which was published on November 3, 2026.
Elementis Earnings release: Q3 2026
Elementis released its Q3 2026 earnings on October 28, 2026, summarizing the period's financial results.
Elementis price target raised to 190 GBp from 186 GBp at JPMorgan
JPMorgan analyst Angelina Glazova raised the firm’s price target on Elementis (EMNSF) to 190 GBp from 186 GBp and keeps a Neutral rating on the shares.
Elementis H1 Earnings Call Highlights
Elementis LON: ELM reported higher first-half revenue, profit and margins as the specialty chemicals company advanced its Elevate Elementis strategy, while management said it remains confident of meet...
Elementis Earnings Call Transcript: H1 2026
Strong H1 2026 results with 5% organic revenue growth, 16% profit increase, and 23% margins, driven by portfolio transformation, innovation, and robust demand in Asia and EMEA. Full-year guidance maintained amid macro uncertainty, with continued focus on growth, cash flow, and capital returns.
Elementis Quarterly report: H1 2026
Elementis has published its H1 2026 quarterly earnings report on July 30, 2026.
Elementis Slides: H1 2026
Elementis has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 30, 2026.
Elementis Earnings release: Q1 2026
Elementis released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
Elementis price target lowered to 200 GBp from 205 GBp at Berenberg
Berenberg analyst Sebastian Bray lowered the firm’s price target on Elementis (EMNSF) to 200 GBp from 205 GBp and keeps a Buy rating on the shares.
Elementis Earnings Call Transcript: H2 2025
Delivered strong profit growth and margin expansion despite a slight revenue decline, driven by strategic divestments, cost savings, and innovation. Personal care outperformed, coatings remained resilient, and the outlook for 2026 is positive with further margin and cash flow improvements expected.
Elementis Annual report: H2 2025
Elementis has published its H2 2025 annual report on March 5, 2026.
Elementis Slides: H2 2025
Elementis has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 5, 2026.
Elementis Annual report: H2 2025
Elementis has published its H2 2025 annual report on March 5, 2026.
Elementis Earnings release: Q4 2025
Elementis released its Q4 2025 earnings on January 21, 2026, summarizing the period's financial results.
Elementis Earnings release: Trading Update
Elementis released its earnings on October 29, 2025, summarizing the period's financial results.
Elementis downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Chetan Udeshi downgraded Elementis (EMNSF) to Neutral from Overweight with an unchanged price target of 186 GBp. The firm sees limited upside potential following the stock’s recent ra...
Elementis price target raised to 200 GBp from 185 GBp at Berenberg
Berenberg analyst Sebastian Bray raised the firm’s price target on Elementis (EMNSF) to 200 GBp from 185 GBp and keeps a Buy rating on the shares.
Elementis price target raised to 200 GBp from 190 GBp at Jefferies
Jefferies raised the firm’s price target on Elementis (EMNSF) to 200 GBp from 190 GBp and keeps a Buy rating on the shares. The company produced an impressive set of…
Elementis Earnings Call Transcript: H1 2025
Strong H1 performance with higher profits and margins, driven by cost savings, innovation, and the sale of the talc business. Specialty additives focus and new strategy set the stage for mid-single-digit growth and sector-leading margins, despite ongoing soft demand.
Elementis Quarterly report: H1 2025
Elementis has published its H1 2025 quarterly earnings report on July 31, 2025.
Elementis Slides: H1 2025
Elementis has posted slides in relation to its H1 2025 quarterly earnings report, which was published on July 31, 2025.
Elementis participates in a conference call with Jefferies
Conference call with new CEO Luc van Ravenstein.will be held on August 1 at 9 am hosted by Jefferies. Webcast Link
Elementis price target raised to 190 GBp from 180 GBp at Jefferies
Jefferies raised the firm’s price target on Elementis (EMNSF) to 190 GBp from 180 GBp and keeps a Buy rating on the shares after updating forecasts ahead of the company’s…
Elementis price target raised to 180 GBp from 175 GBp at Jefferies
Jefferies raised the firm’s price target on Elementis (EMNSF) to 180 GBp from 175 GBp and keeps a Buy rating on the shares. The firm updated its model following the…
Elementis Transcript: Investor Update
The sale of the Talc business for $121 million enables a strategic shift to high-margin specialty chemicals, improving margins and reducing leverage. Proceeds will fund a $50 million share buyback, with future growth focused on coatings and personal care through organic investment and selective bolt-ons.